Viatris announces approval of emissions reduction targets by the science based target initiative (sbti)

Pittsburgh , dec. 14, 2022 /prnewswire/ --  viatris inc.  (nasdaq: vtrs), a global healthcare company, today announced that its near-term science-based emissions reduction targets have been approved by the science based targets initiative (sbti). sbti is a global body enabling businesses to set ambitious emissions reduction targets in line with the latest climate science.
VTRS Ratings Summary
VTRS Quant Ranking